# Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome

> **NCT04046328** · PHASE2 · TERMINATED · sponsor: **Pharmascience Inc.** · enrollment: 13 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Enteric-Coated Cholestyramine (ECC) Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04046328
- **Lead sponsor:** Pharmascience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-15
- **Primary completion:** 2021-12-22
- **Final completion:** 2021-12-22
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Difficult recruitment
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046328, "Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04046328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*